Overdiagnosis: The Hidden Healthcare Problem

When you ponder the various challenges and mistakes of the American healthcare system, which topics do you think of first? High prices, insurance and medical debt, lack of government regulation, and snake-oil treatments may come to mind. However, one of the greatest issues in healthcare today is also one of its least known: Overdiagnosis of medical issues.

Overdiagnosis happens when a health problem is detected and diagnosed despite the fact that it would not have caused harm or when the diagnostic criteria for a particular condition become so broad that they define ordinary experiences as symptoms of disease (Brodersen et al., 2018). A more general definition is a diagnosis that causes more harm than benefit. So what could that harm be? Overdiagnosis may lead to overtreatment, anxiety, and financial damage. The phenomenon has been noted as a problem for people with a wide variety of health conditions, both physical and mental (Brodersen et al., 2018).

For example, a person might be overdiagnosed with cancer after a routine screening finds precancerous cells. Those cells could be so slow-growing that they would never develop into cancer and never cause symptoms. However, if they are diagnosed with cancer, the person will likely feel stressed and scared despite the lack of danger to their health. Who wouldn’t, after hearing “You have cancer” from a trusted healthcare professional? If the possibility of overdiagnosis is not taken into account, the person may also spend large amounts of money on follow-up visits, more testing, and possibly even medication or surgery that will not help them.

What causes overdiagnosis? The most immediate factor is the various health-related screenings that a person undergoes over the course of their lifetime (Dunn et al., 2022). The more screenings they take, the more likely that a disease will be found. This phenomenon has occurred on a nationwide level for various types of cancer within the past few decades. During that time period, more and more new screening tests are being invented, and people are also following recommendations to get screenings more frequently. As a result, the rates of breast, prostate, and other cancers have been on the rise since the 1980s. The tests have especially inflated the rate of early-stage diagnosis, since more advanced technology allows for the identification of subtle anomalies that would not have been flagged by earlier screening methods. At the same time, the rates of late-stage diagnoses have not changed, implying that most of the increase in diagnoses is for cancers that would never have progressed even if they had been undetected (Dunn et al., 2022). (If most of these new and advanced screenings were more effective at detecting cancers that would actually have threatened a person’s health, rates of late-stage and metastatic cancers would decrease, because an earlier diagnosis gives more time for treatment.) Furthermore, careful analysis of the respective death rates for many types of cancer reveals that increases in life expectancy are mostly the result of improvements in cancer treatment (Dunn et al., 2022). Many screenings have no apparent effect on stage of diagnosis or life expectancy; thus, they are likely contributing to overdiagnosis instead.

Thankfully, it may be relatively easy to reduce the frequency of overdiagnosis from screenings. Instead of encouraging mass screening of everyone for every illness, screenings can be targeted towards people at high risk for particular conditions (Dunn et al., 2022). This simple change in policy would likely reduce overdiagnosis and simultaneously allow healthcare providers to focus on the smaller populations of patients who have clear risk factors for a particular disease. Furthermore, greater awareness of overdiagnosis and better communication between the scientific and medical communities and the general public can encourage people to have more nuanced conversations with their doctors about the benefits and drawbacks of screening. Better-educated patients can gain a greater understanding of what screenings can realistically accomplish and whether the chance of catching a treatable illness early on is higher or lower than the chance of overdiagnosis.

Another contributing factor is more difficult to unravel. A number of financial incentives encourage overdiagnosis by expanding what experiences are considered “illness.” Private healthcare companies are often allowed to both diagnose patients and receive state funds per patient being treated, creating a clear conflict of interest. The practice is one of a number of variables that has been implicated in the overdiagnosis of autism. The diagnostic criteria for autism has significantly expanded in the last few decades, partly due to the consolidation of several diagnoses into a single autism spectrum and partly due to other causes, including overreliance on screening questions that are vague and subjective. However, the greatest problem lies in federal and state laws that guarantee certain amounts of funding for healthcare providers regardless of patient need or quality of treatment. In recent years, more people have been diagnosed with relatively mild forms of autism, and yet public spending on behavioral therapy for the condition (which is designed for individuals with more impediments and higher support needs) has skyrocketed (Omary and Singer 2026). The number of people receiving therapy and the number of hours of therapy they receive have also increased, yet treatment is less often individualized (another deviation from its recommended use) and the number of people with more severe forms of autism has remained roughly the same (Omary and Singer 2026). These facts imply that the potential for corporate gain played a role in many newer diagnoses. If this is true, then a significant number of people are being overtreated with therapy that isn’t actually helping them.

Financial conflicts of interest are deeply rooted in our healthcare system, but they aren’t impossible to remove. Recently, Indiana passed a new law to override its previous policy of automatically reimbursing 40% of a healthcare provider’s bill for a particular Medicaid-covered behavioral therapy (Omary and Singer 2026). Under this earlier system, a healthcare company had every incentive to raise prices as much as it wanted. In some cases, companies received payments as large as $29 million to treat fewer than 100 patients with excessive treatments that were not individualized. The new law applies a new, standard reimbursement rate, and it has reduced the amount spent by the state without denying therapy to anyone who was already receiving it. Now that companies can no longer bill the government of Indiana as much as they want per diagnosis, there will likely be fewer overdiagnoses.

A final challenge related to overdiagnosis is the tendency of some observers to disparage the high number of diagnoses of a given health condition by misrepresenting what overdiagnosis means. Many discussions of overdiagnosis have wrongly conflated the phenomenon with false diagnosis or even promoted the idea that people are merely pretending to have certain illnesses in an attempt to explain high diagnosis rates (Davies and Salisbury 2025). This line of reasoning wrongly blames the public for overdiagnosis and fails to offer realistic solutions to the problems it creates. Furthermore, even when a person is overdiagnosed or doesn’t qualify for a particular diagnosis, their concerns about their health are still worthy of being taken seriously. There is a middle ground between overmedicalizing personal experiences and denying that those experiences are legitimate, and it is possible to find it while sympathizing with the people affected by diagnosis and overdiagnosis.

Overdiagnosis is a serious problem in healthcare today, but there are ways to fix it. More regulation of private companies, better health education for the public, and greater awareness can all help reduce both an individual’s likelihood of being overdiagnosed and the number of overdiagnoses on a societal level. Many in health care and academia are working to achieve progress in this area, suggesting ways to prevent health scares and reform broken systems. This advocacy will likely lead to significant changes in the way we diagnose and treat illness, allowing for a future healthcare environment where a “diagnosis” means useful information about what health problems are truly causing harm. No more, no less.

Sources:

Brodersen, J., Schwartz, L. M., Heneghan, C., O’Sullivan, J. W., Aronson, J. K., & Woloshin, S. (2018). Overdiagnosis: What it is and what it isn’t. BMJ Evidence-Based Medicine, 23(1), 1–3. https://doi.org/10.1136/ebmed-2017-110886

Davies, E., & Salisbury, H. (2025). How do we talk about overdiagnosis of mental health conditions without dismissing people’s suffering? BMJ. https://doi.org/10.1136/bmj.r669

Dunn, B. K., Woloshin, S., Xie, H., & Kramer, B. S. (2022, December). Cancer Overdiagnosis: A challenge in the era of screening. ScienceDirect. https://www.sciencedirect.com/science/article/pii/S266700542200059X

Omary, A., & Singer, J. (2026, May 20). Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs. Genetic Literacy Project. https://geneticliteracyproject.org/2026/05/20/financial-incentives-over-diagnosis-and-weak-oversight-autism-claims-are-driving-up-medicare-costs/

Avatar photo
Shelby Wickert

I hope you enjoy reading my articles! I am a Neuroscience major with minors in Spanish and Psychology. In my free time, I enjoy reading, learning new fun facts about a variety of science topics, and exploring the intersection of science, pseudoscience, and pop culture.

Articles: 10